Glutaminergic Neurotoxicity
Several of the most brightly colored (red, pink, gold, blue-gray) Amanita mushrooms (A. muscaria, A. pantherina) are featured prominently in illustrated children's books (A. muscaria in Alice in Wonderland) and are often accidentally ingested by children because of their familiar bright colors or intentionally ingested for their hallucinogenic effects (2) . Their isoxazol-derived constituents, ibotenic acid and muscimol, cause the stimulatory and hallucinogenic effects of these mushrooms. Ibotenic acid resembles glutamic acid structurally and can stimulate central glutaminergic receptors (2) . Muscimol resembles ␥-aminobutyric acid (GABA) structurally and can stimulate central GABA receptors (1) . Within 30 mins to 2 hrs following large ingestions, adults will experience a predominance of muscimol-mediated GABAergic effects including dizziness, somnolence, delirium, dysphoria, and hallucinations (1) . On the other hand, children often experience a preponderance of glutaminergic excitatory effects following unintentional ingestions of ibotenic acid-containing mushrooms (2) . The excitatory manifestations of ibotenic acid poisoning, which can be reversed with intravenous benzodiazepines, include hyperactivity, hyperreflexia, myoclonus, and seizures. In 1992, Benjamin (2) reported the clinical features and management of nine cases of mushroom poisoning from A. pantherina (Panther Amanita, n ϭ 8) and A. muscaria (Fly Amanita, n ϭ 1) admitted to the Seattle Children's Hospital. Most ingestions occurred in male toddlers with onset of neurotoxicity within 30 -180 mins. Clinical features included ataxia, hyperkinetic behavior, intermittent hysteria, hallucinations, and waxing and waning obtundation. Seizures and myoclonic twitching occurred in four of nine patients and were controlled with anticonvulsants. Vomiting was rare. Recovery was rapid and complete in all nine children. Besides benzodiazepines for seizure control, the treatment of ibotenic acid poisoning is supportive; central nervous system toxicity is short-lived, and fatalities are rare (2) .
Gyromitrin-Induced Epileptogenic Neurotoxicity
The gyromitrin-containing, false morel mushrooms (Gyromitra brunnea, G. californica, G. esculenta, G. infula) rarely cause mushroom poisoning in the United States but frequently cause mushroom poisoning in Europe and Scandinavia, where they are commonly mistaken for the prized, edible morel (Morchella esculenta, also known as the conifer edible morel) (1) . Since gyromitrin is watersoluble and highly volatile, vigorous boiling followed by prolonged drying will render Gyromitra mushrooms edible, but amateur mushroom foragers rarely practice these detoxifying steps (3) . KarlsonStiber and Persson (3) reported that the Swedish Poison Information Centre received 706 telephone inquiries on human exposures to Gyromitra esculanta during the period 1994 -2002. Clinical manifestations were mainly gastrointestinal and neurologic, including ataxia, fatigue, nystagmus, tremor, and vertigo (3) . The Swedish Centre recorded no fatalities from Gyromitra mushroom ingestions over the 50 yrs from 1952 to 2002 (4) .
Gyromitrin-containing mushroom poisoning is characterized by self-limited headache, weakness, nausea, vomiting, abdominal cramping, and diarrhea, within 4 -6 hrs of ingestion (3) . This subacute onset of gastrointestinal (GI) toxicity may, rarely, be followed by epileptogenic neurotoxicity, with vertigo, delirium, seizures, stupor, and coma, especially in the elderly and in patients on isoniazid prophylaxis or treatment for tuberculosis (3) (4) (5) . Epileptogenic neurotoxicity results from gyromitrin's activation by phase 1 hydrolysis to its active, primary neurotoxic metabolite, monomethylhydrazine, which, like isoniazid, inhibits pyridoxine, a glutamic acid decarboxylase cofactor, with diminished production of GABA, a central inhibitory neurotransmitter (3, 5) . Thus, isoniazid's side effects, including central neurotoxicity manifesting as seizures, and, possibly, peripheral neurotoxicity manifesting as peripheral neuropathies, may be unmasked and potentiated by gyromitrin poisoning and further pyridoxine inhibition.
Hepatocellular damage, presumably from the formation of free methyl radicals, may follow gyromitrin-induced seizures and is manifested by elevated hepatic transaminases and hyperglycemica, often followed by rebound hypoglycemia (3, 4) . From 1 to 3 days following evidence of hepatic damage, intravascular hemolysis with methemoglobinemia may occur and possibly cause renal damage (3). Fulminant hepatic failure and death are rare following gyromitrin poisoning (3, 4) . Although there are no specific diagnostic tests for gyromitrin poisoning, both chromatography and mass spectrometry may identify monomethylhydrazine and its neurotoxic metabolites (3). The treatment of gyromitrin poisoning includes initial GI decontamination with oral activated charcoal, 1 g/kg of body weight, and seizure control with titrated intravenous doses of benzodiazepines and repeated intravenous boluses of pyridoxine, 25 mg/kg, a specific monomethylhydrazine antidote (3).
Hallucinogenic Neurotoxicity
An acute hallucinogenic or psilocin syndrome, resembling lysergic acid diethylamide (LSD)-induced hallucinations and characterized by ataxia, hallucinations, and hyperkinesis, can be caused by a large variety of psilocybin-containing mushrooms or mellow mushrooms within minutes of ingestion (6) . Common psilocybin-containing mushrooms include Psilocybe cubensis (San Isidro Psilocybe), P. cyanescens (Common WoodChip Psilocybe), P. semilanceata (Liberty Cap Psilocybe), Conocybe cyanopus (Deadly Conocybe), Gymnopilus spectabili (Big Laughing Gym), and Psathyrella foenisecii (Lawn Mower's Mushroom) (3, 6) . Psilocybin-containing mushrooms are frequently cultivated domestically, particularly P. cubensis (San Isidro Psilocybe), for their hallucinogenic effects with spores sold in drug paraphernalia stores ("head shops"), mail-order kits, and over the Internet. In 1988, Schwartz and Smith (7) reported that among 174 adolescents self-identified as substance abusers, 45 (26%) reported ingesting hallucinogenic mushrooms (mean, 2-4 mushrooms per episode), usually in combination with alcohol, marijuana, and other drugs.
Psilocybin and its primary metabolite, psilocin, are centrally acting indoles that resemble LSD and serotonin stereochemically. Psilocybin can act as both a serotonin agonist and antagonist. Although the hallucinogenic effects of psilocybin-containing mushrooms are short-lived and fatalities are rare, renal failure, seizures, and cardiac arrest have occurred after mixed mushroom ingestions, often with alcohol and other drugs, and intravenous injections of hallucinogenic mushroom extracts (8 -11) . Mixed psilocybin-containing mushroom intoxications are usually characterized by anxiety, mydriasis, tachycardia, hypertension, dysphoria, hallucinations, tremor, and dyskinesias (11) . In 1998, Beck and others (12) used gas chromatographymass spectrometry to identify large amounts of phenylethylamine in Psilocybe semilanceata (Liberty Cap Psilocybe) mushrooms ingested by three adolescent males, later hospitalized for adverse reactions. The authors suggested that phenylethylamine, a sympathomimetic amine, could be responsible for the adverse adrenergic reactions, notably hypertension and tachycardia, following Psilocybe mushroom ingestions (12) . Management of hallucinogenic mushroom poisoning is mainly supportive, with benzodiazepines reserved for myoclonus, hyperkinesias, and seizures.
Paxillus Involutus Immunohemolytic Syndrome
The Paxillus syndrome is a rare, and potentially fatal, immunoallergic reaction that may follow the consumption of many common, but inedible, mushroom species, including Paxillus involutus (Poison Pax) and possibly Boletus luridus (Stem Net Bolete) and Clitocybe claviceps (Alcohol Funnel Cap) (13, 14) . The Paxillus syndrome occurs most commonly after the repeated ingestion of Paxillus involutus and is characterized by an acute onset of nausea, vomiting, epigastric pain, and diarrhea within 30 mins to 3 hrs of ingestion (13, 14) . An acute immune complex-mediated hemolytic anemia with hemoglobinuria, oliguria, anuria, and acute renal failure from immune-complex nephritis may follow, possibly initiated by an allergic response to a common Paxillus and Boletus antigenic protein constituent, involutin (13, 14) . Convalescent serum immunoglobulin G antibodies to a Paxillus extract containing involutin have been detected by hemagglutination inhibition testing in several patients with the acute Paxillus syndrome (13, 14) . Treatment of the Paxillus syndrome is entirely supportive and includes hemoperfusion or hemodialysis, and death is rare (13, 14) .
Allergic Pneumonic Syndrome (Lycoperdonosis)
Lycoperdonosis is an acute allergic bronchoalveolitis that is not related to mycotoxin production, as in hemorrhagic pulmonary stachybotryotoxicosis, or to systemic mycosis, as in pulmonary blastomycosis and histoplasmosis (15, 16) . Although not a true poisoning, but an acute bronchopneumonic syndrome, lycoperdonosis may follow the accidental or intentional inhalation or insufflation of spores from Lycoperdon species puffballs, including L. gemmatum (Golden Puffball), L. perlatum (Common Puffball), and L. pyriforme (Stump Puffball) (15, 16) .
Puffballs are often edible in the fall but dry out and decay over the winter and release massive quantities of spores in explosive aerosols when bitten or crushed in the spring and summer. Aerosols of puffball spores have often been used as folk-healing therapies for asthma and bronchitis, for hallucinogenic experimentation by adolescents, and as exploding "land mines" and slingshot-propelled "grenades" by pranksters.
Lycoperdonosis is characterized by the acute onset of nausea, vomiting, and nasopharyngitis, followed within days by fever, malaise, dyspnea, and inflammatory pneumonitis with diffuse reticulonodular infiltrates on chest radiograph (15, 16) . Patients treated with steroids and antifungals, such as amphotericin B, usually recover without chronic bronchopulmonary sequelae (15, 16) . Mechanical ventilation for respiratory failure may be indicated in some cases (15, 16) .
Disulfiram Reaction
Many Coprinus species or inky cap mushrooms, especially C. atramentarius, the ubiquitous alcohol inky caps, contain coprine, an amino acid toxin that inhibits acetaldehyde dehydrogenase and causes acetaldehyde poisoning, a disulfiram-like effect, on ingestion of ethyl alcohol (34) . Coprine poisoning usually occurs when C. atramentarius (Alcohol Inky Cap) is mistaken for the edible C. comatus (Shaggy-Mane Edible Inky Cap) (1, 17, 18) . Alcohol and raw or cooked C. atramantarius co-consumption does not result in an immediate disulfiram effect because of coprine's delayed inhibition of acetaldehyde dehydrogenase over 30 mins to 2 hrs (17, 18) . Investigators now speculate that coprine's primary metabo-lite, 1-aminocyclopropanol, and not coprine, is actually responsible for the delayed disulfiram-like effect (19) . Alcohol consumption within 2 hrs of a coprine-containing mushroom meal will result in tachycardia, facial flushing, diaphoresis, chest pain, nausea, and projectile vomiting, often mimicking an acute myocardial infarction (17) (18) (19) . In addition to coprine-containing inky caps, some prized, edible mushrooms, notably the prized black morel (Morchella angusticeps), may also cause a mild disulfiram reaction if consumed with alcohol (1) ( Table 1 ). The acute disulfiram syndrome is short-lived over a few hours, and treatment is entirely supportive with antiemetics and fluid rehydration. Fatalities are possible from acetaldehyde poisoning with tachyarrhythmias and cardiovascular collapse but are exceedingly rare.
Miscellaneous Gastrointestinal Toxicity Alone
The most common type of mushroom poisoning worldwide is a syndrome of malaise, epigastric pain, nausea, vomiting, and diarrhea that occurs within 30 mins to 3 hrs of ingesting a wide variety of inedible mushrooms and even some edible mushrooms, especially those that have recently decomposed in the field or in storage. Gastrointestinal toxin-containing mushrooms may come from several genera including Boletus, Chlorophyllum, Entoloma, Lactarius, Omphalotus, and Tricholoma (1, 20) . The exact GI toxins have not been identified, leading some investigators to speculate that either allergy or malabsorption may cause the clinical manifestations (20) . Resolution of symptoms occurs rapidly over 6 -24 hrs, and treatment is nonspecific and entirely supportive with antiemetics and fluid rehydration.
LATE-AND DELAYED-ONSET TOXICITY

Late-Onset Toxicity (>6 hrs)
Amatoxic Hepatotoxicity. A triphasic onset of subacute GI toxicity, followed by a false recovery period, and, subsequently, late-onset hepatic failure is pathognomonic of poisoning with cyclopeptide-containing mushrooms (21) . Most mushroom fatalities worldwide continue to be caused by cyclopeptide-containing species from three major genera: a) Amanita (A. bisporigera, A. hygroscopia,
. Amanita phalloides, the ubiquitous Death Cap (Death Angel) Amanita, is generally considered the most toxic of the world's cyclopeptidecontaining Amanita mushrooms, with Galerina species being the least toxic of the cyclopeptide-containing mushrooms (3, 22) . In Eastern Europe, however, Klan (23) found that among 22 species of amatoxic mushrooms (three Amanita, eight Galerina, and 11 Lepiota species), Galerina sulcipes was the most lethal species in humans followed by A. phalloides, A. virosa, G. marginata, and L. brunneoincarnata ( Table 1) .
The cyclopeptides are divided into three classes of high molecular weight peptides: amatoxins, phallotoxins, and virotoxins (24) . The amatoxins, principally ␣-amanitin, are the most toxic cyclopeptides and may be enterohepatically recirculated (25) . Amatoxins cause delayed hepatorenal failure by inactivating RNA polymerase II and inhibiting protein synthesis (26) . The amatoxins exhibit limited protein binding; are eliminated in urine, vomitus, and feces; and may be detected in both bodily fluids and hepatorenal biopsies by chromatography, radioimmunoassay, and enzyme-linked immunosorbent assay (27) . The phallotoxins, principally phalloidin, are rapidly acting but not highly absorbed and cause subacute GI toxicity by reducing mucosal cell membrane integrity (28) . The virotoxins have not been implicated in human toxicity (24) .
As noted, cyclopeptide poisoning may be divided into three phases with phase 1 occurring 6 -24 hrs after mushroom ingestion and presenting a nonspecific, phalloidin-mediated toxidrome of nausea, vomiting, abdominal cramps, and watery diarrhea, which mimics self-limited food poisoning, cholera, or viral gastroenteritis (21) . Since phase 2 is characterized by transient clinical improvement with delayed, asymptomatically rising liver enzymes 18 -36 hrs after ingestion, patients with phase 2 cyclopeptide poisoning may be discharged home, only to return jaundiced with hepatorenal failure within 2-6 days of mushroom ingestion (21, 22) . Phase 3 is characterized by severe gastroenteritis, significantly elevated liver enzymes, and evidence of hepatic, renal, and, often, pancreatic insufficiency (21, 22, 29) . Without intensive care, often including urgent liver transplantation, phase 3 may cause death within a week of ingestion (30, 31) .
In 2003, Forro and Mandli (32) described their experiences in providing anesthetics and critical care to three patients undergoing liver transplantation for fulminant hepatic failure following the ingestion of A. phalloides mushrooms in Hungary. All three patients developed an unanticipated constellation of acute ischemic pancreatitis, disseminated intravascular coagulation, acute renal failure, and gastrointestinal bleeding in the perioperative period. The authors also suggested that amatoxins may have direct cardiovascular depressant effects in addition to their hepatotoxic and nephrotoxic effects and concluded that liver transplantation comprised only a small part of the complex critical care management of A. phalloides poisoned patients (32) .
In 1997, Skaare (33) recommended that the following conditions be included in the differential diagnosis of acute fulminant liver failure, potentially requiring liver transplantation: a) acetaminophen poisoning; b) acute fatty liver of pregnancy; c) viral hepatidides; d) ischemic hepatitis; e) acute Budd-Chiari syndrome; and f) amatoxic mushroom poisoning. In addition, acute fulminant liver failure requiring liver transplantation has occurred following overdoses with the illicit amphetamine, 3,4-methylenedioxymethamphetamine (Ecstasy). For amatoxic mushroom poisoned patients, Skaare (33) recommended early and frequent evaluation of liver function and coagulation status and early referral to a liver transplant center.
In the United States, Klein and colleagues' (34) criteria are often used to evaluate hepatic dysfunction and to recommend liver transplantation in amatoxic mushroom-poisoned patients. Klein and colleagues' (34) criteria are composed of any two of the following conditions: a) grade 2 or higher hepatic encephalopathy; b) prothrombin time twice normal despite procoagulant therapy; c) hypoglycemia requiring continuous glucose infusion; and c) hyperbilirubinemia Ͼ25 mg/dL (425 mmol/L). In European centers, however, other criteria are often used to evaluate hepatic dysfunction and to predict the need for liver transplantation in mushroom poisoning, which occurs more frequently than in the United States.
In 1989, O'Grady and colleagues (35) from the Liver Unit, King's College School of Medicine, in London, were among the first investigators to recognize the need for early prognostic indicators to select those patients most likely to benefit from orthotopic liver transplantation for fulminant liver failure from acetaminophen poisoning, infectious hepatitis, drug reactions, and a variety of miscellaneous causes of acute liver failure, including amatoxic mushroom poisonings. The King's College Hospital prognostic criteria for the selection of patients with fulminant, nonacetaminophen-induced liver failure for orthotopic liver transplantation included prothrombin time Ͼ100 secs (International Normalized Ratio Ͼ 6.5), irrespective of the grade of hepatic encephalopathy, or any of the three following variables, also irrespective of the grade of hepatic encephalopathy: a) age Ͻ10 or Ͼ40 yrs; b) duration of jaundice before onset of hepatic encephalopathy Ͼ7 days; and c) prothrombin time Ͼ50 secs (International Normalized Ratio Ͼ 3.5) and serum bilirubin Ͼ17.5 mg/dL (300 mmol/L) (35 (36) . In addition, the authors noted that fulfillment of the King's College Hospital criteria usually predicted poor outcome regardless of treatment for liver failure (high specificity and positive predictive value), but that lack of fulfillment did not reliably predict survival (low negative predictive value) (36) . In 1991, Ronzoni and coauthors (37) in Milan managed two amatoxic mushroom-poisoned patients who satisfied Klein and colleagues' (34) criteria for liver transplantation with intensive care and without liver transplantation. Both patients awakened from hepatic coma and recovered completely from amatoxin poisoning (37) . At 1-yr follow-up, both patients were in excellent health with normal liver function and no neurologic sequelae of hepatic encephalopathy or hypoglycemia (37) .
In 1996, Bektas and coauthors (38) 
Although Galerina mushroom-poisoned patients usually recover after gastrointestinal phase 1, amatoxin poisoning following ingestion of Lepiota mushrooms may, like Amanita phalloides ingestion, also result in fulminant hepatitis, liver failure, and death (40) . In 1993, Ramirez and others (40) reported the health outcomes in ten patients who had ingested Lepiota species mushrooms in Spain. Seven patients had ingested Lepiota helveola, and the remaining three patients had ingested Lepiota brunneoincarnata (Deadly Lepiota) (40) . Of the ten patients, five recovered completely after gastrointestinal phase 1, and the other five developed hepatic insufficiency (40) . Of the five with hepatic involvement, three patients developed fulminant hepatitis, and two of these died of adult respiratory distress syndrome (40) . The patient with fulminant hepatitis who survived later developed chronic active hepatitis 1 yr after Lepiota ingestion (40) . Finally, five of the surviving eight patients subsequently developed chronic mixed polyneuropathies within the first year after Lepiota poisoning (40) . The authors concluded that liver transplantation might have prevented the two deaths from liver failure with adult respiratory distress syndrome and the single case of chronic active hepatitis following Lepiota poisoning (40) .
Since most patients with amatoxin poisoning are hospitalized after onset of gastrointestinal symptoms, gastric decontamination by lavage has little usefulness beyond 6 hrs postingestion. Although multiple-dose activated charcoal (1 g/kg initially, followed by 0.5 g/kg), administered orally or by gastric tube during the first 3 days postingestion, and intensive care, including fluid resuscitation and possibly liver transplantation, remain the standard of care for amatoxin poisoning, many untested, unapproved therapies have been used over the years. Although not specific antidotes, thioctic acid (41), a free radical scavenger, benzyl penicillin (penicillin G) (42) , silibinin (43) , N-acetylcysteine (NAC) (43) , and cimetidine (44) have all been used in the pharmacologic management of amatoxin poisoning with varying success. In a meta-analysis of 2,108 patients hospitalized in North America and Europe for management of amatoxin poisoning, Enjalbert and coauthors (45) noted that benzyl penicillin alone, or in combination with the other drug therapies noted, was the most frequently used chemotherapy but demonstrated little efficacy. A survival analysis suggested that silibinin administered either alone or in combination or NAC administered alone offered the most effective therapeutic outcomes (45) .
Unlike thioctic acid, both intravenous benzyl penicillin and silibinin have shown some hepatic protection in amatoxin-poisoned mouse models, and cimetidine may offer hepatoprotection by inhibiting cytochrome P450 metabolism of amatoxins, not phallotoxins (42) (43) (44) (45) . Recommended by European experts as safe and effective, intravenous benzyl penicillin, 1 million units/kg/day, may displace amanitin from albumin, block its uptake by hepatocytes, and prevent amanitin from binding to and inhibiting RNA polymerase II (31, 42, 45) .
Silibinin, an extract from the milk thistle, Silybum marianum, may occupy cell membrane binding sites and block amanitin's hepatocellular penetration if administered during the first 3 days postingestion (43, 45) . Silibinin is not easily available in the United States, and its dosage recommendations remain empirical and not evidence-based. Current recommendations for silibinin treatment include an intravenous loading dose of 5 mg/kg administered over 1 hr, followed by a continuous intravenous infusion of 20 mg/kg/day for the first 3 days after amatoxic mushroom ingestions (43) (44) (45) (46) (47) .
Since amatoxins, like acetaminophen, undergo hepatic biotransformation to glutathione-binding, free radical toxic intermediates, NAC, a glutathione precursor, was considered initially as a potentially effective antidote for amanitin poisoning. Although offering effective hepatoprotection in acetaminophen poisoning, NAC has only demonstrated effectiveness in amatoxin poisoning in one case series (44 -47) . In an amatoxinpoisoned mouse model, Schneider and coinvestigators (47) found that NAC (1.2 g/kg) produced no change in survival or in elevation of hepatic enzyme levels compared with control mice not receiving NAC.
Plasmapheresis, hemofiltration, hemoperfusion, and hemodialysis also have not demonstrated any effectiveness in reversing fulminant hepatic failure in phase 3 cyclopeptide poisoning (48 -51) . Although the extracorporeal bioartificial liver has been successful in reversing hepatic failure in acetaminophen poisoning, it has not been tested in human cyclopeptide poisoning but could serve as an effective artificial bridge to hepatic transplantation (52) .
In a series of laboratory experiments in mice, Floersheim (53-56) demonstrated that pretreatment with sublethal doses of phalloidin, ethanol alone, and lyophilized preparations of A. phalloides and kutkin, a mixture of glycosides from the roots of Picrorhiza kurroa, offered some protection against lethal challenges of amatoxins and phallotoxins, possibly by increasing hepatic microsomal detoxification of amatoxins and phallotoxins. In a similar experiment, Zanoli (57) showed that 2,4-monofurfurylidenetetra-O-methyl sorbitol also offered some protection against lethal challenges of amatoxins in mice. In 1977, Floersheim (58) demonstrated that cytochrome c alone or combined with benzyl penicillin completely reversed hepatotoxicity in mice after supralethal doses of ␣-amanitin, even up to 12 hrs postpoisoning. Although the search for specific antidotes to amatoxins continues, any patient with a mushroom ingestion history and physical and laboratory findings suggestive of amatoxin poisoning from Amanita, Galerina, or Lepiota species mushrooms should be initially managed with multiple-dose activated charcoal and supportive therapy and immediately transferred to a regional liver transplantation center for intensive care.
Accelerated Acute Renal Failure. In October 1992, Leray and coauthors (59) managed five cases of acute renal insufficiency following accidental ingestion of Amanita proxima mushrooms by foragers seeking edible Amanita ovoidae mushrooms. All cases were characterized by initial GI toxicity, followed by cytolytic hepatitis and acute renal failure (59) . Although temporary hemodialysis was required in four patients, all patients made favorable recoveries within 3 wks without evidence of chronic hepatic or renal damage (59) . In 1998, deHaro and coauthors (60) reviewed 31 cases of Amanita proxima poisoning reported to the Marseille Poison Center and determined that the initial case was reported in 1968 and that most (n ϭ 26) cases (83%) resulted from confusion with edible Amanita ovoidae mushrooms. The mean onset to clinical manifestations was 13 hrs and 12 mins; all patients had gastrointestinal toxicity, and oliguria or anuria occurred within a few days of ingestion in 14 patients (60). Ten patients had laboratory evidence of hepatic insufficiency, and 11 of 14 patients with renal insufficiency required temporary hemodialysis (60) . Recovery was uniformly favorable in all 31 patients without long-term sequelae (60) .
Between 1992 and 1998, 13 patients in the U.S. Pacific Northwest developed anorexia, malaise, nausea, vomiting, abdominal cramping, diarrhea, diaphoresis, and vertigo within 30 mins to 12 hrs of consuming either raw or cooked Amanita smithiana (Toxic Lepidella Amanita) mushrooms (61) . Many of the poisoned patients were apparently seeking the edible white matsutake mushroom, Tricholoma magnivalere, an A. smithiana look-alike in the U.S. Pacific Northwest (61) . All patients were either oliguric or anuric on presentation and manifested acute renal insufficiency with rising serum blood urea nitrogen and creatinine levels within a week of mushroom ingestion (61) . In addition, both serum alanine aminotransferase and lactic dehydrogenase were frequently elevated, whereas other hepatic enzymes and liver function tests usually remained normal (61) . Although none of the A. smithiana-poisoned patients died, several required hemodialysis up to three times per week for up to 1 month following ingestion (61) . Subsequent in vitro investigations in mice models demonstrated a more rapid onset of renal tubular damage with intraperitoneal allenic norleucine, the amino acid nephrotoxin of A. smithiana, than with orellanine, the interstitial and tubular nephrotoxin of Cortinarius mushrooms (61) (62) (63) .
Treatment of suspected A. proxima and A. smithiana poisoning is primarily supportive and should include GI decontamination with activated charcoal, although of no proven benefit in absorbing allenic norleucine in patients manifesting acute GI toxicity (60, 61) . In addition, the combination of acute GI distress and renal insufficiency following mushroom ingestion should alert clinicians to the possibility of A. proxima poisoning in Europe, or A. smithiana in the United States, and the need for early institution of venovenous charcoal hemoperfusion or hemodialysis (60, 61) .
Erythromelalgia. Erythromelalgia is a painful peripheral, inflammatory condition characterized by intense burning pain, redness, and edema of the hands and feet, often intensified by heat and relieved by cold. Transient erythromelalgia has followed the oral administration of several prescription drugs including bromocriptine (64), verapamil (65) , and nifedipine (66) . The histopathologic examination of skin biopsies in druginduced erythromelalgia has demonstrated perivascular mononuclear infiltration and prominent perivascular dermal edema without vasculitis (64, 65) . In 1918, Ichimura (67) first described mushroom-induced erythromelalgia in Japan within 3 days of consuming Clitocybe acromelalga mushrooms, which resembled the prized edible mushroom, Lepista inversa (Edible Blewit). In 2001, Saviuc and co-authors (68) reported the first European observations of mushroom-induced erythromelalgia in seven French patients within one to several days of consuming Clitocybe amoenolens (Poison Dwarf Bamboo Mushroom) mushrooms, which resemble the edible mushrooms Lepista inversa (Edible Blewit) and Clitocybe gibba (Common Funnel Cap), in the high alpine meadows of France.
All of the French patients with erythromelalgia were characterized by numbness, burning pain, paresthesias, and reddish edema in the fingers and toes with some proximal extension within Ն1 day of mushroom ingestions (68) . There were no associated GI symptoms, and the serum electrolytes and liver enzymes remained normal. In most cases, the pain was worst at night, intensified by heat,
ries developed self-induced trench foot from prolonged ice-water immersion and suffered continuing paresthesias in both feet for 3 yrs (68). Treatment of erythromelalgia is entirely supportive with acetylsalicylic acid, opioids, and analgesic adjuvants, including clonazepam and clomipramine (68) . The exact toxicokinetic mechanisms of erythromelalgia remain unknown but may result from acromelic acid activation of peripheral glutamate pain receptors, including N-methyl-Daspartate, amino-5-methyl-4-isoxazoleproprionic acid, and kainite subtype receptors (68 -71) . Japanese toxicologists have now been identified acromelic acids A-E as the toxic constituents in Clitocybe acromelalgia mushrooms (68 -71).
Delayed-Onset Toxicity (≥ 1 Day)
Delayed Renal Failure. Cortinarius mushrooms (Corts) can cause renal failure following ingestions worldwide (3, 72) . Cortinarius mushrooms contain orellanine, a nephrotoxic bipyridine Noxide. Orellanine inhibits protein synthesis, generates free oxygen radicals, and causes tubulo-interstitial nephritis in rodent models and in humans (3, 72) . The orellanine-containing Cortinarius mushrooms include C. cinnamomeus, C. henrici (C. splendens henrici [Lovely Poisoned Cort]), C. orellanoides, C. orellanus (Deadly Cort), C. rainierensis, and C. speciosissimus (3, 72) . In North America, Cortinarius poisoning predominantly follows ingestion of C. rainierensis (3, 72) . In Europe, Cortinarius poisoning predominately follows ingestion of either C. orellanus or C. speciosissimus (3, (72) (73) (74) .
Cortinarius mushrooms grow in deciduous forests and mountainous regions throughout the temperate world, including Australia, Europe, North America, and the United Kingdom. Cortinariuspoisoned patients will typically present with anorexia, headache, nausea, vomiting, gastritis, and chills within 24 -36 hrs of ingestion (72) (73) (74) . Oliguric renal failure due to interstitial nephritis and tubular necrosis with later fibrosis will develop in most cases days to weeks following mushroom ingestion (72) (73) (74) . Although most patients regain nearnormal renal function following shortterm hemodialysis, 40 -60% of Cortinarius-poisoned patients may develop chronic renal failure and require chronic hemodialysis or renal transplantation (72) (73) (74) .
In 1957, Grzymala (73) reported a series of 102 Polish patients with orellanine poisoning following the ingestion of Cortinarius orellanus (Deadly Cort) mushrooms. In this initial report of human Cortinarius poisoning, there were 11 deaths, for a case fatality rate of 11% (73) . In 1990, Bouget and others (74) reported a series of 26 French patients hospitalized for periods of 10 -12 days following C. orellanus ingestions. Twelve patients presented with acute tubulo-interstitial nephritis and acute renal failure, requiring hemodialysis in eight patients, and 14 patients presented with normal renal function, although 12 had initial leukocyturia (74) . In this series, the incidence of end-stage renal failure requiring hemodialysis and subsequent renal transplantation was 8%, similar to the 11% case fatality rate reported by Grzymala in Poland during the prerenal transplant era (73, 74) . In a 2001 review of 90 patients hospitalized after Cortinarius ingestions, Danel and coauthors (72) reported acute renal failure with progression to chronic renal failure in half of the patients, with intermittent hemodialysis or renal transplantation required in 70% of those patients. In a 1995 review of 22 patients treated for Cortinarius ingestions in Sweden over the period 1979 -1993, Holmdahl and Blohmé (75) reported that nine of 22 patients (41%) developed chronic renal failure requiring hemodialysis or renal transplantation.
Although orellanine can be detected by thin-layer chromatography on renal biopsy specimens for months after Cortinarius poisoning, there are no specific laboratory tests to predict outcomes after Cortinarius ingestions (74, 75) . Only the onset times of GI toxicity and subsequent nephrotoxicity will assist clinicians in differentiating A. smithiana from Cortinarius poisoning (3, 62, 72, 74 -76) . Acute GI toxicity within 6 hrs followed by subacute nephrotoxicity within 24 -36 hrs suggests A. smithiana poisoning (3, 61) . Subacute GI toxicity within 24 -36 hrs followed days to weeks later (mean, 8.5 days) by nephrotoxicity suggests Cortinarius poisoning (62, 72, 74 -76) .
In a meta-analysis of 245 patients with 90 patients analyzed in precise detail, Danel and coauthors (72) described the main clinical and histopathologic features of orellanine poisoning following Cortinarius mushroom ingestion. Most of the patients included in the metaanalysis came from Poland and included Grzymala's patients and other Polish patients (n ϭ 135); patients from France (n ϭ 45), Sweden (n ϭ 26), and Austria (n ϭ 16); and patients from several other western European countries (72, 73) . The responsible Cortinarius species mushrooms were identified by experts in 90 patients and included Cortinarius orellanus in 58.9%, Cortinarius speciosissimus in 20%, Cortinarius splendens henrici in 15.6%, Cortinarius cinnamomeus in 1.1%, and unspeciated Cortinarius mushrooms in 5.6% (72, 73) .
The mean onset time to initial presenting, mainly GI, symptoms was 3 days (72) . In the prerenal phase, vomiting occurred in 62.7% of 82 patients, polydipsia in 45.8%, flank pain in 36.1%, nausea in 36.1%, and abdominal pain in 24.1% (72) . The renal phase of orellanine poisoning was delayed by a mean period of 8.5 days in all patients and was characterized by leukocyturia in 50% of 62 patients, hematuria in 45.2%, proteinuria in 30.6%, and leukocytosis in 17.7% (72) . Histopathologic features on initial renal biopsies in 36 patients at a mean postingestion time of 25 days demonstrated tubular damages (lesions, necrosis, atrophy) in 77.8%, inflammatory infiltrates in 69.4%, interstitial edema in 55.6%, and fibrosis in 38.9% (72) .
As in other reported series of Cortinarius poisonings, there were no clinical or laboratory indications of liver injury in any patient (72) (73) (74) (75) . Neuromuscular symptoms were, however, observed in 20% of the patients, preceded the renal phase, and included limb paresthesias, muscle cramps, and myalgias. Although there was no reported laboratory evidence (elevated serum creatine phosphokinase [CPK] levels) of rhabdomyolysis in Cortinarius-poisoned patients, neuromuscular symptoms in the prerenal phase could mimic Tricholoma equestre (Yellow Trich) or Russula subnigricans (Blackening Russula) poisoning with myalgias and rhabdomyolysis (72, 74, 75, 77, 78) . Health status and treatment outcomes in 62 patients with acute renal failure included 32 patients with chronic renal insufficiency with most patients (69%) requiring hemodialysis or peritoneal dialysis, and of these, 12 patients required renal transplantation. There were five deaths among 90 Cortinariuspoisoned patients, primarily in those (n ϭ 62) with renal failure, for a case fatality rate of 5.6% (72) .
Early treatment of known Cortinarius ingestions should include immediate gastric emptying and GI decontamination with activated charcoal, which has not been proven to absorb either orelline or orellanine (72) . Early secondary decontamination by either plasmapheresis or hemoperfusion is also of no proven benefit in removing orellanine and preventing renal failure after Cortinarius ingestions (3, 72, 74, 75) . The treatment protocol for Cortinarius ingestions should include hemoperfusion for renal insufficiency, hemodialysis or peritoneal dialysis for short-term renal failure, and chronic hemodialysis or renal transplantation for chronic renal failure (3, 72, 74, 75) . Renal transplantation should not be performed too early in the course of illness, as complete renal recovery may occur in 40 -60% of Cortinarius-poisoned patients (3). In the series reported by Danel and coauthors (72) , the median time to renal transplantation was 10 months (range, 6 -30 months).
Delayed Central Nervous System Failure. In the 1990s, three people in Germany developed decreased visual acuity, somnolence, weakness, and reduced motor tone and activity Ն24 hrs following the ingestion of Hapalopilus rutilans (Purple-Dye Polypore) mushrooms (79, 80) . Laboratory studies demonstrated electrolyte abnormalities and hepatorenal insufficiency (80) . In 1998, Kraft and coinvestigators (80) in Germany identified polyporic acid, a dihydroorotate dehydrogenase inhibitor, as the toxic constituent in Hapalopilus rutilans, using rodent models. Rats developed reduced locomotor activity, depressed visual placing responses, electrolyte disturbances, and hepatorenal failure within Ն24 hrs of polyporic acid administration, with all symptoms and laboratory derangements resembling those observed in the three poisoned patients (80) . The management of Hapalopilus poisoning is supportive with gastric decontamination by orogastric lavage, if within 6 hrs of ingestion, multiple-dose activated charcoal, restoration of fluid and electrolyte balance, and short-term hemoperfusion, peritoneal dialysis, or hemodialysis for acute renal insufficiency (79, 80 (77) . Over the next 4 days, all patients developed worsening weakness, especially in the quadriceps, facial erythema, nausea without vomiting, and diaphoresis without fever (77) . All patients were hospitalized and demonstrated evidence of severe rhabdomyolysis with mean maximum serum CPK levels of 22,067 units/L in women (n ϭ 7) and 34,786 units/L in men (n ϭ 5) (77) . Electromyography demonstrated muscle injury without peripheral nerve involvement, and quadriceps muscle biopsies were consistent with direct muscle damage (77) . In 2002, another two cases of T. equestre with rhabdomyolysis were reported from Poland (81) . An outbreak of delayed rhabdomyolysis with acute renal insufficiency in the most severely poisoned patients was also reported from Taiwan in 2001, following the ingestion of Russula subnigricans (Blackening Russula) (82) .
Three of the French patients died despite intensive care, including venovenous hemofiltration, after developing severe hyperthermia (to 42°C), dyspnea at rest, acute myocarditis, and QRS complex widening without severe acidosis (77) . Postmortem examinations demonstrated myocardial lesions similar to the striated muscle biopsy lesions in one patient, renal lesions in one patient, and no hepatic lesions (77) . In the nine survivors, the serum CPK levels normalized over 2 wks, but muscular weakness persisted for several weeks (77) . French investigators were later able to demonstrate increased CPK levels and similar observed muscle weakness and myopathic lesions in mice receiving equivalent human doses of T. equestre extracts (77) . Although the yellow pigment of T. equestre and several metabolites from various Tricholoma species have now been isolated, the toxic compound in T. equestre remains to be identified (77, (81) (82) (83) (84) .
The subacute onset of fatigue and muscle weakness with little GI distress following yellow mushroom consumption should arouse suspicion of T. equestre poisoning (77) . All patients should be hospitalized for supportive care, serum CPK monitoring, and forced alkaline diuresis for renal protection from myoglobinuria (77, (81) (82) .
Although some Tricholoma species are consumed in the United States and in Japan, particularly Tricholoma magnivalere (T. matsutake), the white matsutake mushroom, many Tricholoma species mushrooms can cause mild, selflimited GI toxicity, with nausea, vomiting, abdominal cramps, and diarrhea (75, (83) (84) (85) (86) . Tricholoma pardinum is colloquially called the "dirty Trich" mushroom in the United States because of its frequent association with GI toxicity (86) .
The French cluster of 12 mushroom poisonings by T. equestre was particularly exceptional for several reasons including a) it had a high case fatality rate of 25%; b) it involved a unique onset of myotoxicity followed by rhabdomyolysis without vomiting, severe GI toxicity, or hepatorenal failure; and c) it involved a popular, edible mushroom that later became highly toxic only after cooking and repeated consumption (77) . In summary, no wild or uncultivated mushroom should ever be eaten raw or consumed in large quantities as main courses. Even some edible mushrooms, such as the morel-like Verpa bohemica (Wrinkled Cap Bell Morel), may cause GI toxicity when cooked, especially if eaten in excess (1).
CONCLUSIONS
Several new toxidromes, some with fatal outcomes, have been described in the United States and Europe, including subacute myopathy with subsequent rhabdomyolysis following ingestion of Tricholoma equestre, acute renal failure following ingestion of Amanita proxima or A. smithiana, erythromelalgia following ingestion of Clitocybe amoenolens, and delayed central nervous system failure following ingestion of Hapalopilus rutilans.
Gastrointestinal mushroom poisoning continues to occur commonly, as more amateur mushroom hunters are fooled by look-alikes, consume wild mushrooms raw, or overindulge on cooked mush- rooms, often with alcohol. Hallucinogenic mushroom poisoning is also occurring more commonly with more fatalities as adolescents and young adults are encouraged to experiment with natural neurotoxins by peers, spore-selling pushers, enticing Web sites, and drug paraphernalia shopkeepers. Clinicians must consider mushroom poisoning in the evaluation of all patients who may be intoxicated by natural substances. Since information on natural exposures is often insufficient and incorrect, a new toxidromic classification of mushroom poisoning is recommended to guide clinicians in making earlier diagnoses, especially in cases where only advanced care, such as liver or kidney transplantation, may be life saving (Table 1) .
